GlassScriptPhysician profile
Matthew W Bradley
NPI 1134342918
$6,635.70
in general payments reported to CMS, 2019-2025
14 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,743 · 2020: $76.65 · 2021: $580 · 2022: $909 · 2023: $862 · 2024: $853 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,720 · Travel and Lodging: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,719.73 |
| Travel and Lodging | $606.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,788.22 | 2019-2025 | Mako, Triathlon, Insignia |
| Elite Orthopedics, LLC | $1,067.74 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $593.43 | 2019-2020 | |
| Organogenesis INC. | $306.70 | 2022-2025 | Puraply Wound Matrix, Nushield, Via Matrix |
| Motive Health, INC. | $260.79 | 2019 | |
| Heraeus Medical, LLC. | $211.05 | 2021-2022 | |
| Alafair Biosciences, INC. | $177.11 | 2025 | Versawrap |
| Axogen | $102.13 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Electronic Waveform Lab, INC. | $25.13 | 2019 | |
| Heron Therapeutics, INC. | $23.87 | 2021 | |
| Smith+Nephew, INC. | $22.40 | 2025 | Pico 14, Pico 7 |
| Avion Pharmaceuticals | $22.08 | 2023 | Methylphenidate Hydrochloride |
| Abbott Laboratories | $19.28 | 2021 | |
| Davol INC. | $15.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.